AAAAAA

   
Results: 1-12 |
Results: 12
CYTOPLASMIC LOCALIZATION OF ANTHRACYCLINE ANTITUMOR DRUGS CONJUGATED WITH REDUCED GLUTATHIONE - A POSSIBLE CORRELATION WITH MULTIDRUG-RESISTANCE MECHANISMS
Authors: SERAFINO A SINIBALDIVALLEBONA P GAUDIANO G KOCH TH RASI G GARACI E RAVAGNAN G
Citation: A. Serafino et al., CYTOPLASMIC LOCALIZATION OF ANTHRACYCLINE ANTITUMOR DRUGS CONJUGATED WITH REDUCED GLUTATHIONE - A POSSIBLE CORRELATION WITH MULTIDRUG-RESISTANCE MECHANISMS, Anticancer research, 18(2A), 1998, pp. 1159-1166
WHO BENEFITS FROM IMMUNOTHERAPY
Authors: BONINI S RASI G
Citation: S. Bonini et G. Rasi, WHO BENEFITS FROM IMMUNOTHERAPY, Allergy, 52(7), 1997, pp. 693-694
COMBINATION THERAPY WITH BRMS IN CANCER AND INFECTIOUS-DISEASES
Authors: GARACI E PICA F RASI G PALAMARA AT FAVALLI C
Citation: E. Garaci et al., COMBINATION THERAPY WITH BRMS IN CANCER AND INFECTIOUS-DISEASES, Mechanism of ageing and development, 96(1-3), 1997, pp. 103-116
COMBINATION LOW-DOSE LYMPHOBLASTOID INTERFERON AND THYMOSIN ALPHA(1) THERAPY IN THE TREATMENT OF CHRONIC HEPATITIS-B
Authors: RASI G MUTCHNICK MG DIVIRGILIO D SINIBALDIVALLEBONA P PIERIMARCHI P COLELLA F FAVALLI C GARACI E
Citation: G. Rasi et al., COMBINATION LOW-DOSE LYMPHOBLASTOID INTERFERON AND THYMOSIN ALPHA(1) THERAPY IN THE TREATMENT OF CHRONIC HEPATITIS-B, Journal of viral hepatitis, 3(4), 1996, pp. 191-196
A NEW TUMOR-ASSOCIATED ANTIGEN OF NONSMALL CELL LUNG-CANCER - TUMOR LIBERATED PROTEINS (TLP) - A POSSIBLE NEW TUMOR-MARKER
Authors: GARACI E SINIBALDI P RASI G
Citation: E. Garaci et al., A NEW TUMOR-ASSOCIATED ANTIGEN OF NONSMALL CELL LUNG-CANCER - TUMOR LIBERATED PROTEINS (TLP) - A POSSIBLE NEW TUMOR-MARKER, Anticancer research, 16(4B), 1996, pp. 2253-2255
COMBINATION THYMOSIN ALPHA(1) AND LYMPHOBLASTOID INTERFERON TREATMENTIN CHRONIC HEPATITIS-C
Authors: RASI G DIVIRGILIO D MUTCHNICK MG COLELLA F SINIBALDIVALLEBONA P PIERIMARCHI P VALLI B GARACI E
Citation: G. Rasi et al., COMBINATION THYMOSIN ALPHA(1) AND LYMPHOBLASTOID INTERFERON TREATMENTIN CHRONIC HEPATITIS-C, Gut, 39(5), 1996, pp. 679-683
SEQUENTIAL CHEMOIMMUNOTHERAPY FOR ADVANCED NON-SMALL-CELL LUNG-CANCERUSING CISPLATIN, ETOPOSIDE, THYMOSIN-ALPHA-1 AND INTERFERON-ALPHA-2A
Authors: GARACI E LOPEZ M BONSIGNORE G DELLAGIULIA M DAPRILE M FAVALLI C RASI G SANTINI S CAPOMOLLA E VICI P DILAURO L
Citation: E. Garaci et al., SEQUENTIAL CHEMOIMMUNOTHERAPY FOR ADVANCED NON-SMALL-CELL LUNG-CANCERUSING CISPLATIN, ETOPOSIDE, THYMOSIN-ALPHA-1 AND INTERFERON-ALPHA-2A, European journal of cancer, 31A(13-14), 1995, pp. 2403-2405
SEQUENTIAL BIOCHEMOTHERAPY FOR METASTATIC COLORECTAL-CANCER USING, FLUOROURACIL, FOLINIC ACID, THYMOPENTIN AND INTERLEUKIN-2 - CLINICAL ANDIMMUNOLOGICAL EFFECTS
Authors: LOPEZ M DILAURO L PAOLETTI G SANTINI S GANDOLFO GM VITELLI G FRASCA AM AMEGLIO F RASI G GARACI E
Citation: M. Lopez et al., SEQUENTIAL BIOCHEMOTHERAPY FOR METASTATIC COLORECTAL-CANCER USING, FLUOROURACIL, FOLINIC ACID, THYMOPENTIN AND INTERLEUKIN-2 - CLINICAL ANDIMMUNOLOGICAL EFFECTS, Annals of oncology, 6(10), 1995, pp. 1011-1017
COMBINATION THYMOSIN-ALPHA(1) (T-ALPHA(1)) AND LYMPHOBLASTOID INTERFERON (L-IFN) THERAPY IN CHRONIC HEPATITIS-C (CHC)
Authors: RASI G MUTCHNICK MG DIVIRGILIO D PIERIMARCHI P SINIBALDIVALLEBONA P COLELLA F GARACI E
Citation: G. Rasi et al., COMBINATION THYMOSIN-ALPHA(1) (T-ALPHA(1)) AND LYMPHOBLASTOID INTERFERON (L-IFN) THERAPY IN CHRONIC HEPATITIS-C (CHC), Gastroenterology, 108(4), 1995, pp. 1153-1153
BIOCHEMOTHERAPY WITH THYMOSIN-ALPHA-1, INTERLEUKIN-2 AND DACARBAZINE IN PATIENTS WITH METASTATIC MELANOMA - CLINICAL AND IMMUNOLOGICAL EFFECTS
Authors: LOPEZ M CARPANO S CAVALIERE R DILAURO L AMEGLIO F VITELLI G FRASCA AM VICI P PIGNATTI F ROSSELLI M RASI G GARACI E
Citation: M. Lopez et al., BIOCHEMOTHERAPY WITH THYMOSIN-ALPHA-1, INTERLEUKIN-2 AND DACARBAZINE IN PATIENTS WITH METASTATIC MELANOMA - CLINICAL AND IMMUNOLOGICAL EFFECTS, Annals of oncology, 5(8), 1994, pp. 741-746
COMBINATION LOW-DOSE LYMPHOBLASTOID INTERFERON (L-IFN-ALPHA) AND THYMOSIN-ALPHA(1) (T-ALPHA(1)) THERAPY IN THE TREATMENT OF CHRONIC HEPATITIS-B
Authors: RASI G MUTCHNICK MG DIVIRGILIO D PIERIMARCHI P SINIBALDIVALLEBONA P COLELLA F FAVALLI C GARACI E
Citation: G. Rasi et al., COMBINATION LOW-DOSE LYMPHOBLASTOID INTERFERON (L-IFN-ALPHA) AND THYMOSIN-ALPHA(1) (T-ALPHA(1)) THERAPY IN THE TREATMENT OF CHRONIC HEPATITIS-B, Hepatology, 20(4), 1994, pp. 10000299-10000299
ANTITUMOR EFFECT OF COMBINED TREATMENT WITH THYMOSIN ALPHA-1 AND INTERLEUKIN-2 AFTER 5-FLUOROURACIL IN LIVER METASTASES FROM COLORECTAL-CANCER IN RATS
Authors: RASI G SILECCHIA G SINIBALDIVALLEBONA P SPAZIANI E PIERIMARCHI P SIVILIA M TREMITERRA S GARACI E
Citation: G. Rasi et al., ANTITUMOR EFFECT OF COMBINED TREATMENT WITH THYMOSIN ALPHA-1 AND INTERLEUKIN-2 AFTER 5-FLUOROURACIL IN LIVER METASTASES FROM COLORECTAL-CANCER IN RATS, International journal of cancer, 57(5), 1994, pp. 701-705
Risultati: 1-12 |